Location and General data


Istituto Lusofarmaco D'Italia S.p.A.

Single Member Company

Registered Office
Strada 6, Edificio L,
20089 Milanofiori Rozzano (Mi)
Tel. 0039-02-516555.1
Telefax 0039-02-516555249

Administrative Office
Via Sette Santi, 3
50131 Florence
Italy
Tel. 0039-055-5680.1
Telefax 0039-055-5680488
 
Registration No. in Registrar of Companies: 00714810157
Registrar of Companies' Office: Milan
Registered capital: € 130,000 fully paid-in
Capital Reported in Last Financial Statement: € 130,000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

I nostri prodotti

Lusofarmaco può vantare un ampio know how in varie aree terapeutiche: dalle patologie cardiovascolari alle malattie respiratorie, dall’antibioticoterapia alla neuropsichiatria e per finire l'area ginecologica.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.

Ricerca e sviluppo

Per molti anni, la connotazione di Lusofarmaco è stata quella di una azienda di rilievo essenzialmente nazionale, con un listino incentrato su farmaci di consolidata esperienza.

Pharmacovigilance

The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

Farmacovigilanza

È la scienza relativa all’individuazione, la valutazione, la comprensione e la prevenzione degli effetti avversi o di ogni altro problema legato ai farmaci.

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1 - Fax 02-516555.249

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl

SITEMAP

Copyright 2021 Istituto Lusofarmaco D'Italia S.p.A.